Chinese Equities Down 17% in October

November 02, 2022 | David Hernandez, CFA, Director of Traditional Manager Search

2022 has been a difficult year for Chinese equities, which are now down 43% year-to-date through October. In comparison, the MSCI Emerging Markets (EM) ex China Index is down 23% over the same period, while the MSCI World Index, a developed markets benchmark, is down 20%. It has been a seesaw year so far as Chinese equities underperformed in the first quarter, down 14% while the EM ex China index lost 3%. In the second quarter, China was one of the few countries to generate a positive return (+3%) as the EM ex China benchmark declined 18%. In the third quarter, the China index was down sharply again – -22% – with the sell-off carrying into October as other markets globally rebounded. China was down 17% in October – the worst month for the country benchmark in 11 years.

Over the course of the year there have been three key challenges to Chinese equities: 1) continuation of the zero-COVID policy, 2) property sector troubles, and 3) geopolitical issues. For most of the year, markets have reacted to various news and events centered on these three topics. More recently, markets turned sharply negative following the country’s Party Congress where President Xi Jinping was elected to an unprecedented third term and further consolidated power within the newly elected governing body. While there were hopes that the focus would shift to the economy following the Party Congress, President Xi went on to reaffirm China’s zero-COVID policy, casting a shadow over future economic growth. Chinese equities fell 8% the day after the Party Congress concluded, ending the month down 17%. Trailing and forward price-to-earnings multiples now sit close to twenty-year lows. From here, markets are likely to remain choppy, presenting both risks and opportunities to investors, until there is additional clarity regarding China’s zero-COVID policy and property sector, as well as broader geopolitical issues and China’s intentions.

Print PDF > Chinese Equities Down 17% in October

 

The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

David Hernandez, CFA
Director of Traditional Manager Search

Get to Know David

The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

Related Content

Line chart showing 10-year U.S. Treasury rate, 5-year/5-year breakeven inflation rate, and 10-year real yield from December 2025 through September 2026. The left axis shows rates from 3.6% to 5.4%, and the right axis from 1.6% to 3.0%. The Treasury rate and real yield rise notably in late 2026, while the breakeven inflation rate remains relatively range-bound around 2.3%–2.4%. For full dataset, please contact marquettemarketing@marquetteassociates.com.

09.28.2026

Getting Real on Inflation

The phrase “expectations of higher inflation” has become a staple in financial news to explain the increase in nominal U.S….

Dual-axis line chart comparing LBO/M&A/Recapitalization Activity, its average level, and the SOFR (90-Day) rate from 3Q18 through 2Q26. LBO/M&A/Recapitalization Activity ranges from approximately $0 billion to $100 billion, while SOFR ranges from 0% to approximately 5%. For full dataset, please contact marquettemarketing@marquetteassociates.com.

09.21.2026

Let’s Make a Deal

For much of the past several years, the conventional view has been that higher interest rates and stretched valuations would…

Line chart comparing annualized return and annualized risk for stock-bond portfolio combinations from 1976-2019 and 2020-2026. Two lines show the range of return and risk outcomes across portfolio allocations during each period. For full dataset, please contact marquettemarketing@marquetteassociates.com.

09.14.2026

No More Free Lunch?

There are many great things about working at Marquette Associates, but “Free Lunch Tuesday” is right at the top of…

Combination stacked column and line chart comparing EMD fund flows (columns) and index cumulative returns (lines), June 2024 to present. Indices used: JPM EMBI GD Index and JPM GBI EM GD Index. Since May 2025, Monthly Flows have been positive, with the exception of March 2026. Most recent datapoint: July 31, 2026 Hard Currency Flows $1.2B, Local Currency $1.6B, JPM EMBI GD Index at 21.2%, JPM GBI EM GD Index at 23.1%. For full dataset, please contact marquettemarketing@marquetteassociates.com.

09.08.2026

EMD’s Second Chance?

Over the last several years, emerging market debt (EMD) has faced several headwinds, with rising yields across other fixed income…

Combination stacked column and line chart showing U.S. Buyout (private equity) Net Asset Value holding periods, 2011 to 2025. Column categories include holding periods

08.31.2026

Zombie, Inc.

Private equity has always had a few portfolio companies that refused to leave the party. Today, however, the industry appears…

Five-line chart comparing yield on 30-year debt instrument for the United States, United Kingdon, France, Germany, and Japan, December 2021 to August 21, 2026. First data point in order listed previously: 1.9%, 1.1%, 0.9%, 0.2%, 0.7%. Most recent: 5.3%, 5.8%, 4.9%, 3.8%, 4.1%. For full dataset, please contact marquettemarketing@marquetteassociates.com.

08.24.2026

Long Weakened

The global bond market is facing renewed pressure as investors demand higher yields to hold long-dated government debt, pushing borrowing…

More articles

Subscribe to Research Email Alerts

Research Email Alert Subscription

Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.

We respect your privacy. We will never share or sell your information.

Thank You

We appreciate your interest in Marquette Associates.

If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.

Contact Us >